HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
AMGN
AMGEN Inc
Healthcare Drug Manufacturers - General · California, USA · Reports in usd
Market Cap: $182.85B
Market Cap
$182.85B
Enterprise Val
$228.33B
P/E Ratio
23.71
P/B Ratio
21.12
Trailing PEG (1Y)
0.21
As Of
Apr 27, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$8.66B
Gross Margin69.84%
Profit Margin69.84%
Return on Equity96.65%
Return on Assets8.62%
Current Ratio1.14
Debt/Equity6.31
LT Debt/Equity5.78
Revenue Per Share18.32

Income Statement

Dec 31, 2025
Revenue$9.87B
Cost of Revenue$2.98B
Gross Profit$6.89B
R&D$2.14B
SG&A$1.95B
Operating Expenses$4.17B
Operating Income$2.72B
Interest Expense$653.0M
Tax Expense$181.0M
Net Income$1.33B
EPS (Basic)$2.47
EPS (Diluted)$2.46
EBIT$2.17B
EBITDA$3.30B
Consolidated Income$1.33B
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$9.13B
Accounts Receivable$9.57B
Inventory$6.23B
Current Assets$29.06B
LT Investments$0.00
Property, Plant & Equipment$7.91B
Intangibles$40.96B
Non-Current Assets$61.53B
Total Assets$90.59B
Accounts Payable$2.37B
Current Debt$4.60B
Current Liabilities$25.49B
LT Debt$50.01B
Non-Current Liabilities$56.44B
Total Liabilities$81.93B
Total Debt$54.60B
Retained Earnings-$25.11B
Shareholder Equity$8.66B
Shares Outstanding538,480,671

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$1.60B
Investing Cash Flow-$693.0M
Financing Cash Flow-$1.23B
CapEx-$642.0M
Free Cash Flow$961.0M
Depreciation & Amort.$1.13B
Stock-Based Comp$125.0M
Acquisitions / Disposals-$53.0M
Investment Activity$0.00
Debt Issued/Repaid$0.00
Equity Issued/Repaid$0.00
Dividends Paid-$1.28B
Net Change in Cash-$316.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h